Vu Le

953 total citations
29 papers, 802 citations indexed

About

Vu Le is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Vu Le has authored 29 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Vu Le's work include DNA and Nucleic Acid Chemistry (11 papers), Advanced biosensing and bioanalysis techniques (7 papers) and RNA Interference and Gene Delivery (6 papers). Vu Le is often cited by papers focused on DNA and Nucleic Acid Chemistry (11 papers), Advanced biosensing and bioanalysis techniques (7 papers) and RNA Interference and Gene Delivery (6 papers). Vu Le collaborates with scholars based in United States, India and Belgium. Vu Le's co-authors include Edwin A. Lewis, Robert Buscaglia, Jingjing Cui, Jonathan B. Chaires, Narayana Nagesh, Andrzej Syguła, Michael Yanney, Melissa O’Gorman, Joseph P. Emerson and Fathima S. Ameer and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and The Journal of Physical Chemistry B.

In The Last Decade

Vu Le

29 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vu Le United States 18 491 107 104 96 58 29 802
Enguerran Vanquelef France 7 541 1.1× 192 1.8× 137 1.3× 58 0.6× 36 0.6× 9 833
Zhiyan Li China 19 447 0.9× 245 2.3× 223 2.1× 72 0.8× 56 1.0× 64 1.0k
N. Sukumar United States 15 504 1.0× 77 0.7× 180 1.7× 38 0.4× 96 1.7× 35 827
Qianfan Yang China 22 1.2k 2.5× 132 1.2× 145 1.4× 117 1.2× 73 1.3× 56 1.5k
Tam L. Nguyen United States 14 409 0.8× 180 1.7× 88 0.8× 158 1.6× 48 0.8× 25 875
Tatyana S. Godovikova Russia 15 409 0.8× 73 0.7× 100 1.0× 54 0.6× 85 1.5× 46 745
Pamela D. Twigg United States 8 616 1.3× 73 0.7× 178 1.7× 168 1.8× 43 0.7× 11 799
Roger Lahana France 17 467 1.0× 439 4.1× 131 1.3× 89 0.9× 31 0.5× 33 1.1k
Shengxi Chen United States 22 802 1.6× 231 2.2× 91 0.9× 108 1.1× 49 0.8× 68 1.2k
Wenjie Zhang China 19 287 0.6× 150 1.4× 184 1.8× 110 1.1× 21 0.4× 44 970

Countries citing papers authored by Vu Le

Since Specialization
Citations

This map shows the geographic impact of Vu Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vu Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vu Le more than expected).

Fields of papers citing papers by Vu Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vu Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vu Le. The network helps show where Vu Le may publish in the future.

Co-authorship network of co-authors of Vu Le

This figure shows the co-authorship network connecting the top 25 collaborators of Vu Le. A scholar is included among the top collaborators of Vu Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vu Le. Vu Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sagawa, Kazuko, Vivek S. Purohit, Vu Le, et al.. (2025). Virtual Bioequivalence Assessment of Tofacitinib Once Daily Modified Release Dosage Form in Pediatric Subjects. The AAPS Journal. 27(3). 71–71. 4 indexed citations
3.
Wang, Xiaoxing, Martin E. Dowty, Svitlana Tatulych, et al.. (2022). Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals. European Journal of Drug Metabolism and Pharmacokinetics. 47(3). 419–429. 22 indexed citations
4.
Lockwood, Peter, Vu Le, Melissa O’Gorman, et al.. (2020). The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers. Clinical Pharmacology in Drug Development. 9(7). 849–854. 37 indexed citations
6.
Le, Vu, et al.. (2015). ITC Methods for Assessing Buffer/Protein Interactions from the Perturbation of Steady-State Kinetics. Methods in enzymology on CD-ROM/Methods in enzymology. 567. 257–278. 4 indexed citations
7.
Le, Vu, et al.. (2015). Calorimetric and spectroscopic investigations of the binding of metallated porphyrins to G-quadruplex DNA. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(5). 902–909. 32 indexed citations
9.
Ding, Lei, et al.. (2014). Recognition and Binding of Human Telomeric G-Quadruplex DNA by Unfolding Protein 1. Biochemistry. 53(20). 3347–3356. 31 indexed citations
10.
Lyons, Daniel F., Vu Le, Gene L. Bidwell, et al.. (2013). Structural and Hydrodynamic Analysis of a Novel Drug Delivery Vector: ELP[V5G3A2-150]. Biophysical Journal. 104(9). 2009–2021. 22 indexed citations
11.
Le, Vu, Narayana Nagesh, & Edwin A. Lewis. (2013). Bcl-2 Promoter Sequence G-Quadruplex Interactions with Three Planar and Non-Planar Cationic Porphyrins: TMPyP4, TMPyP3, and TMPyP2. PLoS ONE. 8(8). e72462–e72462. 51 indexed citations
12.
Rowland, Gerald B., et al.. (2013). The effect of pyridyl substituents on the thermodynamics of porphyrin binding to G-quadruplex DNA. Bioorganic & Medicinal Chemistry. 21(23). 7515–7522. 21 indexed citations
13.
Machha, Venkata R., et al.. (2013). Calorimetric studies of the interactions of linker histone H10 and its carboxyl (H10–C) and globular (H10–G) domains with calf-thymus DNA. Biophysical Chemistry. 184. 22–28. 5 indexed citations
14.
Cui, Jingjing, et al.. (2013). The Effect of Molecular Crowding on the Stability of Human c-MYC Promoter Sequence I-Motif at Neutral pH. Molecules. 18(10). 12751–12767. 103 indexed citations
15.
Le, Vu, et al.. (2013). Role of Water in Netropsin Binding to an A2T2 Hairpin DNA Site: Osmotic Stress Experiments. The Journal of Physical Chemistry B. 117(50). 15958–15965. 1 indexed citations
16.
Le, Vu, et al.. (2012). Exploring substrate binding in homoprotocatechuate 2,3-dioxygenase using isothermal titration calorimetry. JBIC Journal of Biological Inorganic Chemistry. 17(7). 991–994. 8 indexed citations
17.
Ameer, Fathima S., Vu Le, Edwin A. Lewis, et al.. (2012). Studying Protein and Gold Nanoparticle Interaction Using Organothiols as Molecular Probes. The Journal of Physical Chemistry C. 116(5). 3645–3652. 56 indexed citations
18.
Buscaglia, Robert, et al.. (2011). DSC Deconvolution of the Structural Complexity of c-MYC P1 Promoter G-Quadruplexes. Biophysical Journal. 100(6). 1517–1525. 31 indexed citations
19.
Lewis, Edwin A., Manoj Munde, Michael F. Rettig, et al.. (2011). Complexity in the binding of minor groove agents: netropsin has two thermodynamically different DNA binding modes at a single site. Nucleic Acids Research. 39(22). 9649–9658. 30 indexed citations
20.
Evans, Rebecca M., Timothy Nicholas, Vu Le, et al.. (2010). O3‐05‐04: Safety and pharmacokinetics of PF‐04447943, a PDEA inhibitor, in single and multiple dose Phase 1 studies in healthy volunteers. Alzheimer s & Dementia. 6(4S_Part_5). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026